MediaMedic

EBMT 2025 | Dr. Alice Bertaina Presents Promising Results from T-allo10 Immunotherapy in Pediatric and Young Adult Patients with Hematologic Malignancies

By Mourabit Halima 2025.04.12

At the EBMT 2025 Congress, Dr. Alice Bertaina (Stanford University, USA) presented encouraging Phase Ia data on T-allo10 immunotherapy following TCRαβ-depleted hematopoietic stem cell transplantation (HSCT) in pediatric and young adult patients with hematologic malignancies.

EBMT 2025 | Prof. Gandhi Damaj Shares Updated Consensus on Allogeneic Transplantation in Peripheral T-cell Lymphoma (PTCL)

By Mourabit Halima 2025.04.12

At this year’s EBMT Congress in Florence, Prof. Gandhi Damaj (Hematology Institute, Normandy University, France) presented the latest recommendations from the EBMT Practice Harmonisation and Guidelines Committee on allogeneic hematopoietic cell transplantation (allo-HCT) in PTCL.

Can minor histocompatibility antigens (mHAgs) unlock new predictive power in GvHD risk stratification?

By Peng Longmei 2025.04.12

At EBMT 2025, Dr. Nicoletta Cieri (Dana-Farber Cancer Institute) delivered a forward-looking presentation exploring the prognostic potential of mHAg load in allogeneic hematopoietic cell transplantation (allo-HCT).Her findings suggest that systematic…

EBMT 2025 | GVHD Prophylaxis in Haploidentical HSCT for R/R AML: Insights from Dr. Giorgia Battipaglia

By Mourabit Halima 2025.04.12

At EBMT 2025, Dr. Giorgia Battipaglia shared important findings from a multicenter study comparing post-transplant cyclophosphamide (PTCy) versus antithymocyte globulin (ATG) as GVHD prophylaxis in patients with relapsed/refractory AML undergoing…

GVHD Prophylaxis in Intermediate-Risk AML: Mixed Results from a Multicenter Trial

By Mourabit Halima 2025.04.12

At EBMT 2025, Dr. Edouard Forcade presented the results of a multicenter randomized trial comparing cyclosporine (CsA) alone versus CsA plus mycophenolate mofetil (MMF) in patients with intermediate-risk AML in…

ASCO GI 2025 | Prof. Ying Yuan & Prof. Kefeng Ding on BB+CAPOX in RAS-Mutant MSS mCRC

By Yin, Jiale 2025.04.12

At ASCO GI 2025, Prof. Ying Yuan shared updated data from the BB+CAPOX Phase II trial, showing a median PFS of 25.3 months in liver-only RAS-mutant MSS mCRC. Prof. Kefeng Ding highlighted the potential of this combo to convert immune-cold tumors into responsive disease.

ASCO GI 2025 | Spotlight on SHR1701 from Peking University Cancer Hospital

By Mourabit Halima 2025.04.11

At the ASCO GI 2025 Symposium in San Francisco, experts from Peking University Cancer Hospital presented new data on SHR1701, a PD-L1/TGF-βR2 fusion protein. The Phase III results showed both survival benefits and a reduction in chemotherapy-induced myelosuppression in advanced gastric and GEJ cancers.

2026 Cross-Strait Hematology Academic Conference | Huiju Tsai: Empowering Transplant Care with the TBMT APP and Advancing Nursing Development Through Cross-Strait Collaboration

2026 Cross-Strait Hematology Academic Conference | Dr. Sheng‑Hsuan Chien: From Taiwan’s Experience to Precision Transfusion—Exploring the Path Forward for Patient Blood Management (PBM)

Gaobo Medical Forum 2026 | Professor Dehui Zou: Precision Positioning and Optimization Strategies for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma in the Era of Novel Therapies

Gaobo Medical Forum 2026 | Dr. Su Li: A Comprehensive Analysis of BCMA/GPRC5D Dual-Target CAR-T Therapy in RRMM—Mechanisms, Efficacy, and Combination Strategies

CSCO 2026 Outlook | Professor Jun Ma: Hematologic Malignancies Continue to Lead Innovation, Advancing Oncology Toward Long-Term Survival

Professor Jun Zhu: Precision Strategies in Hematopoietic Stem Cell Transplantation — From the Clinical Positioning of Autologous Transplantation to Comprehensive Management of HLH丨Gaobo Medical Forum 2026

2026 Cross-Strait Hematology Academic Conference | Nursing Experts from Both Sides Discuss New Practices in Critical Hematology Care and Infection Prevention in Transplantation

Gaobo Medical Forum 2026 | Dr. Shan Shao: New GVHD Prophylaxis Strategies and Individualized Approaches for CNI-Intolerant Patients Undergoing Allogeneic Transplantation

Gaobo Medical Forum 2026 | Dr. Huixia Liu: Strategies and Clinical Practice of Allogeneic Transplantation for Older Patients with Acute Leukemia

2026 Cross-Strait Hematology Academic Conference | Professor Xiaowen Tang: Biological Features of TP53-Abnormal B-ALL and Strategies for Optimizing CAR-T Therapy

2026 Cross-Strait Hematology Academic Conference | Huiju Tsai: Empowering Transplant Care with the TBMT APP and Advancing Nursing Development Through Cross-Strait Collaboration

2026 Cross-Strait Hematology Academic Conference | Dr. Sheng‑Hsuan Chien: From Taiwan’s Experience to Precision Transfusion—Exploring the Path Forward for Patient Blood Management (PBM)

EBMT 2025 | Dr. Alice Bertaina Presents Promising Results from T-allo10 Immunotherapy in Pediatric and Young Adult Patients with Hematologic Malignancies

EBMT 2025 | Prof. Gandhi Damaj Shares Updated Consensus on Allogeneic Transplantation in Peripheral T-cell Lymphoma (PTCL)

Can minor histocompatibility antigens (mHAgs) unlock new predictive power in GvHD risk stratification?

EBMT 2025 | GVHD Prophylaxis in Haploidentical HSCT for R/R AML: Insights from Dr. Giorgia Battipaglia

GVHD Prophylaxis in Intermediate-Risk AML: Mixed Results from a Multicenter Trial

ASCO GI 2025 | Prof. Ying Yuan & Prof. Kefeng Ding on BB+CAPOX in RAS-Mutant MSS mCRC

ASCO GI 2025 | Spotlight on SHR1701 from Peking University Cancer Hospital

Sebastian Giebel Presents at EBMT 2025: How Prior alloHCT Shapes CART19 Outcomes in B-ALL

EBMT 2025 | Dr. maria victoria mateos manteca on MRD as a Surrogate Marker in Myeloma Outcomes

Allogeneic SCT in Follicular Lymphoma: Still a Valid Option in the Modern Therapeutic Landscape

2026 Cross-Strait Hematology Academic Conference | Huiju Tsai: Empowering Transplant Care with the TBMT APP and Advancing Nursing Development Through Cross-Strait Collaboration

2026 Cross-Strait Hematology Academic Conference | Dr. Sheng‑Hsuan Chien: From Taiwan’s Experience to Precision Transfusion—Exploring the Path Forward for Patient Blood Management (PBM)

Gaobo Medical Forum 2026 | Professor Dehui Zou: Precision Positioning and Optimization Strategies for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma in the Era of Novel Therapies

Gaobo Medical Forum 2026 | Dr. Su Li: A Comprehensive Analysis of BCMA/GPRC5D Dual-Target CAR-T Therapy in RRMM—Mechanisms, Efficacy, and Combination Strategies

Welcome to Mediamedic 👋
It’s nice to meet you.

Welcome to Mediamedic 👋It’s nice to meet you.

Welcome to Mediamedic 👋
It’s nice to meet you.